Bill summaries are authored by CRS.

Shown Here:
Passed House amended (12/18/2015)

Global Health Innovation Act of 2015

(Sec. 2) This bill directs the U.S. Agency for International Development (USAID) to report annually for four years to Congress regarding:

  • the extent to which global health innovations include drugs, diagnostics, devices, vaccines, electronic and mobile health technologies, and related behavior change and service delivery innovations;
  • how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases;
  • how goals are set for health product development in relation to USAID's health-related goals;
  • how USAID is leveraging U.S. investments to achieve greater impact in health innovation, developing and introducing affordable global health products, and increasing health innovations in the development pipeline;
  • how USAID is coordinating with other federal departments and agencies in support of global health product development; and
  • how USAID is coordinating and aligning global health innovation activities between the Global Development Lab, the Center for Accelerating Innovation and Impact, and the Bureau for Global Health.